The disruption of ICOS-ICOSLsignaling prevents autoantibody formation and organ inflammation in Rc3h1 mice and othermurine models of autoimmune diseases, such as SLE-like disease, collagen-inducedarthritis, and myasthenia gravis (53, , -56). Here, ICOS is linked to systemic lupus erythematosus.